Septerna, Inc. (SEPN)
NASDAQ: SEPN · Real-Time Price · USD
26.76
+0.60 (2.29%)
Dec 5, 2025, 4:00 PM EST - Market closed

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023
Period Ending
Dec '23
G Protein-coupled Receptor
151.00K

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023
Period Ending
Dec '23
United States
151.00K